TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancer

TRAIL receptor I (DR4) polymorphisms C626G and A683C are associated with an increased risk for hepatocellular carcinoma (HCC) in HCV-infected patients

(2012) Christian Körner et al.   BMC CANCER

miR-493 induction during carcinogenesis blocks metastatic settlement of colon cancer cells in liver

(2012) Koji Okamoto et al.   EMBO JOURNAL

A Study of Ethnic Differences in TGFβ1 Gene Polymorphisms and Effects on the Risk of Radiation Pneumonitis in Non–Small-Cell Lung Cancer

(2012) Xiaomin Niu et al.   Journal of Thoracic Oncology

Interleukin-10 Haplotype May Predict Survival and Relapse in Resected Non-Small Cell Lung Cancer

(2012) Yaw-Cheng Wang et al.   PLoS One

TNFRSF1B +676 T>G polymorphism predicts survival of non-Small cell lung cancer patients treated with chemoradiotherapy

(2011) Xiaoxiang Guan et al.   BMC CANCER

Association of death receptor 4, Caspase 3 and 5 gene polymorphism with increased risk to bladder cancer in North Indians

(2011) R.D. Mittal et al.   EJSO

Death Receptor 5 and cellular FLICE-inhibitory protein regulate pemetrexed-induced apoptosis in human lung cancer cells

(2011) Ling Su et al.   EUROPEAN JOURNAL OF CANCER

Association of death receptor 4 variant (683A>C) with ovarian cancer risk in BRCA1 mutation carriers

(2011) Michelle G. Dick et al.   INTERNATIONAL JOURNAL OF CANCER

Genome-Wide Association Study of Survival in Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy

(2011) Xifeng Wu et al.   JNCI-Journal of the National Cancer Institute

Paclitaxel Induces Apoptosis Through Activation of Nuclear Protein Kinase C-δ and Subsequent Activation of Golgi Associated Cdk1 in Human Hormone Refractory Prostate Cancer

(2011) Pin-Hsuan Lu et al.   JOURNAL OF UROLOGY

Epidemiology of Lung Cancer

(2011) Aoife McErlean et al.   SEMINARS IN ROENTGENOLOGY

Cytokines in Cancer Immunotherapy

(2011) Sylvia Lee et al.   Cancers

Polymorphisms in Apoptosis-Related Genes and Survival of Patients with Early-Stage Non-Small-Cell Lung Cancer

(2010) Eung Bae Lee et al.   ANNALS OF SURGICAL ONCOLOGY

Evolutionary evidence of the effect of rare variants on disease etiology

(2010) IP Gorlov et al.   CLINICAL GENETICS

Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis

(2010) Linlang Guo et al.   EUROPEAN JOURNAL OF CANCER

Predominant antitumor effects by fully human anti-TRAIL-receptor2 (DR5) monoclonal antibodies in human glioma cells in vitro and in vivo

(2010) M. Nagane et al.   NEURO-ONCOLOGY

Genetic Variants in Inflammation-Related Genes Are Associated with Radiation-Induced Toxicity Following Treatment for Non-Small Cell Lung Cancer

(2010) Michelle A. T. Hildebrandt et al.   PLoS One

Role of Inflammation Gene Polymorphisms on Pain Severity in Lung Cancer Patients

(2009) C. C. Reyes-Gibby et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

TRAIL-R1 polymorphisms and cancer susceptibility: An evidence-based meta-analysis

(2009) Bo Chen et al.   EUROPEAN JOURNAL OF CANCER

SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies

(2009) Zongli Xu et al.   NUCLEIC ACIDS RESEARCH

Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy

(2008) Katharina Leithner et al.   LUNG CANCER